Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析

◆英語タイトル:Bone Therapeutics SA (BOTHE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH305698FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, for delayed-union fractures, spinal fusion procedures, frevision spinal fusion. Bone Therapeutics conducts preclinical research on next generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications. The company conducts clinical studies for treatment of delayed-union fractures and spinal fusion. Bone Therapeutics is headquartered in Gosselies, Belgium.

Bone Therapeutics SA Key Recent Developments

Mar 30,2021: Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer
Mar 17,2021: Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference
Mar 17,2021: 3/17/21 – Bone Therapeutics to present in M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference
Jan 20,2021: Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

This comprehensive SWOT profile of Bone Therapeutics SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bone Therapeutics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Bone Therapeutics SA – Key Information
Bone Therapeutics SA – Overview
Bone Therapeutics SA – Key Employees
Bone Therapeutics SA – Key Employee Biographies
Bone Therapeutics SA – Key Operational Heads
Bone Therapeutics SA – Major Products and Services
Bone Therapeutics SA – History
Bone Therapeutics SA – Company Statement
Bone Therapeutics SA – Locations And Subsidiaries
Bone Therapeutics SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Bone Therapeutics SA – Business Description
Bone Therapeutics SA – Corporate Strategy
Bone Therapeutics SA – SWOT Analysis
SWOT Analysis – Overview
Bone Therapeutics SA – Strengths
Bone Therapeutics SA – Weaknesses
Bone Therapeutics SA – Opportunities
Bone Therapeutics SA – Threats
Bone Therapeutics SA – Key Competitors

Section 3 – Company Financial Performance Charts

Bone Therapeutics SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Bone Therapeutics SA, Key Information
Bone Therapeutics SA, Key Ratios
Bone Therapeutics SA, Share Data
Bone Therapeutics SA, Major Products and Services
Bone Therapeutics SA, History
Bone Therapeutics SA, Key Employees
Bone Therapeutics SA, Key Employee Biographies
Bone Therapeutics SA, Key Operational Heads
Bone Therapeutics SA, Other Locations
Bone Therapeutics SA, Subsidiaries
Bone Therapeutics SA, Key Competitors
Bone Therapeutics SA, SWOT Analysis
Bone Therapeutics SA, Ratios based on current share price
Bone Therapeutics SA, Annual Ratios
Bone Therapeutics SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • aTyr Pharma Inc (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • The Medicines Company (MDCO):製薬・医療:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • State Bank of India:企業のM&A・事業提携・投資動向
    State Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Accenture Plc (ACN):企業の財務・戦略的SWOT分析
    Accenture Plc (ACN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Hollard Insurance Group:企業の戦略・SWOT・財務情報
    Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • IDFC Ltd (IDFC):企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Synthetic Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company offers DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages. It offers solutions in genomics research, bioproduction, a …
  • EmCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EmCare Inc (EmCare) is a healthcare service provider that offers emergency department outsourcing services for the hospitals. The center provides emergency medicine, hospital medicine, acute care surgery, anesthesiology and radiology services. It provides recruitment, staffing, management, m …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • McKesson Corp (MCK)-医療機器分野:企業M&A・提携分析
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes ethical and proprietary drugs and equipment and health and beauty care products in North America and overseas. The company also develops and provides decision support software a …
  • Kvaerner ASA (KVAER):企業の財務・戦略的SWOT分析
    Kvaerner ASA (KVAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wolters Kluwer nv:企業の戦略・SWOT・財務情報
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Klockner Pentaplast GmbH & Co. KG:戦略・SWOT・企業財務分析
    Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ascential plc:企業の戦略・SWOT・財務情報
    Ascential plc - Strategy, SWOT and Corporate Finance Report Summary Ascential plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆